Cargando…

Inhibitory Effects of (—)‐Epigallocatechin Gallate on Spontaneous Hepatoma in C3H/HeNCrj Mice and Human Hepatoma‐derived PLC/PRF/5 Cells

The inhibitory effect of (—)‐epigallocatechin gallate (EGCG), a main constituent of Japanese green tea, on spontaneous hepatoma in C3H/HeNCrj mice was investigated. A total of 72 mice were divided into three groups; the control group without EGCG, and two experimental groups receiving 0.05% (w/w) or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishida, Hiroshi, Omori, Masahide, Fukutomi, Yasushi, Ninomiya, Mitsuo, Nishiwaki, Shinji, Suganuma, Masami, Moriwaki, Hisataka, Muto, Yasutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919446/ https://www.ncbi.nlm.nih.gov/pubmed/7514585 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02085.x

Ejemplares similares

Inhibitory Effects of Acyclic Retinoid (Polyprenoic Acid) and Its Hydroxy Derivative on Cell Growth and on Secretion of α‐Fetoprotein in Human Hepatoma‐derived Cell Line (PLC/PRF/5)
por: Fukutomi, Yasushi, et al.
Publicado: (1990)

Inhibitory Effect of Sarcophytol A on Development of Spontaneous Hepatomas in Mice
por: Yamauchi, Osamu, et al.
Publicado: (1991)

Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-α
por: Hung, W-C, et al.
Publicado: (1999)

Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
por: Nakagawa, T., et al.
Publicado: (1985)

Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing
por: Ishii, Tomotaka, et al.
Publicado: (2020)

Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013)

Tropical Cirrhosis and Hepatoma
por: Coady, Anthony
Publicado: (1976)

(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis
por: Sumi, Takafumi, et al.
Publicado: (2013)

The Surgical Treatment of the Solitary Hepatoma
Publicado: (1931)

Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate
por: Fujiki, Hirota, et al.
Publicado: (2017)

Age-Dependent Decrease in Hepatic Geranylgeranoic Acid Content in C3H/HeN Mice and Its Oral Supplementation Prevents Spontaneous Hepatoma
por: Tabata, Yuki, et al.
Publicado: (2021)

Inhibitory Effect of Genistein on PLC/PRF5 Hepatocellular Carcinoma Cell Line
por: Dastjerdi, Mehdi Nikbakht, et al.
Publicado: (2015)

Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
por: Fukutomi, Ryuuta, et al.
Publicado: (2021)

Immunogenicity of Rat Hepatoma Membrane Fractions
por: Baldwin, R. W., et al.
Publicado: (1973)

Mortality of hepatoma and cirrhosis of liver in Taiwan.
por: Lin, T. M., et al.
Publicado: (1986)

Cytoplasmic Ribonucleoprotein Components of the Novikoff Hepatoma
por: Kuff, Edward L., et al.
Publicado: (1960)

Hepatoma (Primary Liver-Celled Carcinoma)
por: Bose, A. C.
Publicado: (1942)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Responsiveness of enzymes in liver to growth of Novikoff hepatoma.
por: Wu, C., et al.
Publicado: (1969)

Hepatoma and groundnuts in the West Nile district of Uganda.
por: Korobkin, M., et al.
Publicado: (1968)

Immunogenic Properties of Rat Hepatoma Subcellular Fractions
por: Price, M. R., et al.
Publicado: (1974)

Molecular mobility and nucleocytoplasmic flux in hepatoma cells
Publicado: (1986)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Studies on Isolated Tumour Mitochondria: Biochemical Properties of Mitochondria from Hepatomas with Special Reference to a Transplanted Rat Hepatoma of the Solid Type
por: Emmelot, P., et al.
Publicado: (1959)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Heat-shock proteins and mRNAs in liver and hepatoma.
por: Bardella, L., et al.
Publicado: (1987)

A histological Study of the Latent Period of Hepatoma Grafts
por: Head, Mary A., et al.
Publicado: (1961)

Induction of Hepatomas in Rats and Mice following the Administration of Auramine
por: Williams, M. H. C., et al.
Publicado: (1962)

THE REPLICATION TIME AND PATTERN OF CARCINOGEN-INDUCED HEPATOMA CELLS
por: Post, Joseph, et al.
Publicado: (1964)

FORMATION OF MEMBRANE-GLYCOGEN ARRAYS IN RAT HEPATOMA CELLS
por: Flaks, Bojan
Publicado: (1968)

UNUSUAL ASPECTS OF ULTRASTRUCTURAL DIFFERENTIATION IN RAT HEPATOMA CELLS
por: Flaks, Bojan
Publicado: (1968)

Antigenic differences in nuclear proteins of normal liver and hepatoma
por: Ruoslahti, E, et al.
Publicado: (1977)

Lectin of Concanavalin A as an anti-hepatoma therapeutic agent
por: Lei, Huan-Yao, et al.
Publicado: (2009)

Dynamics and Control of the Central Carbon Metabolism in Hepatoma Cells
por: Maier, Klaus, et al.
Publicado: (2010)

Permissiveness of human hepatoma cell lines for HCV infection
por: Sainz, Bruno, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_248v144cdgh0r04ns9lmpdtl0k